- Patent Title: Removal of tumor cells from intraoperative autologous blood salvage
-
Application No.: US14349898Application Date: 2012-10-04
-
Publication No.: US09605242B2Publication Date: 2017-03-28
- Inventor: Horst Lindhofer , Michael Stroehlein , Markus Heiss
- Applicant: Trion Pharma GmbH
- Applicant Address: DE Munich
- Assignee: Horst Lindhofer
- Current Assignee: Horst Lindhofer
- Current Assignee Address: DE Munich
- Agency: Jenkins, Wilson, Taylor & Hunt, P.A.
- Priority: EP11183851 20111004
- International Application: PCT/EP2012/069584 WO 20121004
- International Announcement: WO2013/050445 WO 20130411
- Main IPC: A61K35/14
- IPC: A61K35/14 ; G01N33/574 ; C07K16/30 ; C12N5/00 ; C07K16/28 ; A61K35/18 ; C07K16/46 ; C12N5/078

Abstract:
The invention relates to a method performed ex vivo for removal of tumor cells from intraoperatively collected blood salvage, to antibodies and scaffold proteins which mimic antibodies for use in said ex vivo method, to the use of said ex vivo method for removal of tumor cells from intraoperatively collected blood salvage followed by reintroducing the so obtained purified blood salvage or of concentrates of erythrocytes purified by said method to a patient from whom said intra-operatively collected blood was obtained, as well as to blood salvage or a concentrate of erythrocytes, both obtainable by said method for reinfusion to said patient.
Public/Granted literature
- US20140369985A1 REMOVAL OF TUMOR CELLS FROM INTRAOPERATIVE AUTOLOGOUS BLOOD SALVAGE Public/Granted day:2014-12-18
Information query
IPC分类: